June 5, 2022 SanaCurrents Portfolio Update: APLS files NDA, IMUX UC drug falters in phase II topline, plus VERA and ACET This content is for members only
May 14, 2022 SanaCurrents Speculative on Adicet’s (ACET) upcoming gamma-delta cancer data at the June ASCO meeting This content is for members only